ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $341,425 | +30.3% | 8,452 | +129.3% | 0.00% | – |
| Q1 2022 | $262,000 | -5.1% | 3,686 | +0.1% | 0.00% | – |
| Q4 2021 | $276,000 | -99.3% | 3,684 | -99.4% | 0.00% | -100.0% |
| Q4 2019 | $39,651,000 | -23.7% | 641,818 | -25.8% | 0.02% | -28.6% |
| Q3 2019 | $51,988,000 | -34.8% | 865,309 | -8.4% | 0.03% | -34.9% |
| Q2 2019 | $79,721,000 | -4.6% | 944,787 | +8.1% | 0.04% | -6.5% |
| Q1 2019 | $83,522,000 | +57.7% | 874,397 | +17.0% | 0.05% | +35.3% |
| Q4 2018 | $52,952,000 | +389.4% | 747,593 | +490.5% | 0.03% | +466.7% |
| Q3 2018 | $10,820,000 | -26.3% | 126,610 | -0.0% | 0.01% | -25.0% |
| Q2 2018 | $14,675,000 | -63.3% | 126,619 | -74.4% | 0.01% | -66.7% |
| Q1 2018 | $39,994,000 | – | 494,298 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |